| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology |
Endocrine Sciences Research Group [A. S., J. S., D. W. R.] and Department of Medicine [P. E. B., S. R.], Stopford Building, University of Manchester, Manchester M13 9PT, United Kingdom
The human vascular endothelial growth factor (VEGF) gene is unusually polymorphic,and there is evidence for inheritance of conserved haplotypes.One haplotype, carrying polymorphisms at -460/+405, is associated with enhanced production of VEGF in vitro. The VEGF promoter is activated by phorbol esters and, in endometrial cells, by estrogen. We have analyzed the impact of the common -460/+405 polymorphism on both basal and stimulated VEGF transcription using the human breast cancer cell line MCF7. Because the VEGF promoter is so highly polymorphic, haplotypes were established and analyzed. Carriage of the -460/+405 polymorphisms increased basal promoter activity by 71% compared with the wild-type sequence. However, this effect was dependent on colinearity with a series of further 5' sequence polymorphisms. The -460/+405 polymorphism also increased the mean induction by phorbol ester from 5-fold to 8.5-fold. In contrast to earlier studies in endometrial cells, none of the human VEGF promoter constructs was regulated by estrogen. Overexpression of the estrogen receptor did not confer estrogen regulation to VEGF, implying cell type-specific hormonal regulation. Therefore, carriage of the -460/+405 polymorphism significantly alters VEGF promoter activity and responsiveness. This has implications for the inherited susceptibility of common diseases.
This article has been cited by other articles:
|
|
 |
|
  M. Patel, S. Ailawadhi, F. Hernandez-Ilizaliturri, and G. E. Wilding Vascular Endothelial Growth Factor Polymorphisms in Early-Stage Non-Small-Cell Lung Cancer J. Clin. Oncol., July 1, 2008; 26(19): 3289 - 3290. [Full Text] [PDF]
|
|
|
|
|
|
R. S. Heist, R. Zhai, G. Liu, W. Zhou, X. Lin, L. Su, K. Asomaning, T. J. Lynch, J. C. Wain, and D. C. Christiani VEGF Polymorphisms and Survival in Early-Stage Non-Small-Cell Lung Cancer J. Clin. Oncol., February 20, 2008; 26(6): 856 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zhai, G. Liu, W. Zhou, L. Su, R. S. Heist, T. J. Lynch, J. C. Wain, K. Asomaning, X. Lin, and D. C. Christiani Vascular Endothelial Growth Factor Genotypes, Haplotypes, Gender, and the Risk of Non-Small Cell Lung Cancer Clin. Cancer Res., January 15, 2008; 14(2): 612 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Kim, Y. S. Chae, S. K. Sohn, Y. Y. Cho, J. H. Moon, J. Y. Park, S. W. Jeon, I. T. Lee, G. S. Choi, and S.-H. Jun Vascular Endothelial Growth Factor Gene Polymorphisms Associated with Prognosis for Patients with Colorectal Cancer Clin. Cancer Res., January 1, 2008; 14(1): 62 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Y. Debrah, S. Mand, M. R. Toliat, Y. Marfo-Debrekyei, L. Batsa, P. Nurnberg, B. Lawson, O. Adjei, A. Hoerauf, and K. Pfarr Plasma Vascular Endothelial Growth Factor-A (VEGF-A) and VEGF-A Gene Polymorphism are Associated with Hydrocele Development in Lymphatic Filariasis Am J Trop Med Hyg, October 1, 2007; 77(4): 601 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kitsios and E. Zintzaras Genetic Variation associated with Ischemic Heart Failure: A HuGE Review and Meta-Analysis Am. J. Epidemiol., September 15, 2007; 166(6): 619 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Zhai, M N Gong, W Zhou, T B Thompson, P Kraft, L Su, and D C Christiani Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS Thorax, August 1, 2007; 62(8): 718 - 722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chalothorn, J. A. Clayton, H. Zhang, D. Pomp, and J. E. Faber Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains Physiol Genomics, July 18, 2007; 30(2): 179 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kim, S. Sohn, Y. Chae, Y. Cho, H-I Bae, G Yan, J. Park, M-H Lee, H. Chung, and W Yu Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer Ann. Onc., June 1, 2007; 18(6): 1030 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Buraczynska, P. Ksiazek, I. Baranowicz-Gaszczyk, and L. Jozwiak Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients Nephrol. Dial. Transplant., March 1, 2007; 22(3): 827 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Churchill, J. G. Carter, H. C. Lovell, C. Ramsden, S. J. Turner, A. Yeung, J. Escardo, and D. Atan VEGF polymorphisms are associated with neovascular age-related macular degeneration Hum. Mol. Genet., October 1, 2006; 15(19): 2955 - 2961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S M Hyder Sex-steroid regulation of vascular endothelial growth factor in breast cancer. Endocr. Relat. Cancer, September 1, 2006; 13(3): 667 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Garside, C. Waters, A. Berry, L. Rice, H. C Ardley, A. White, P. A Robinson, and D. Ray UbcH7 interacts with the glucocorticoid receptor and mediates receptor autoregulation. J. Endocrinol., September 1, 2006; 190(3): 621 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Higashi, S. Kyo, M. Inoue, H. Tanii, and K. Saijoh Novel Functional Single Nucleotide Polymorphisms in the Latent Transforming Growth Factor-{beta} Binding Protein-1L Promoter: Effect on Latent Transforming Growth Factor-{beta} Binding Protein-1L Expression Level and Possible Prognostic Significance in Ovarian Cancer J. Mol. Diagn., July 1, 2006; 8(3): 342 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kataoka, Q. Cai, W. Wen, X.-O. Shu, F. Jin, Y.-T. Gao, and W. Zheng Population-Based Case-Control Study of VEGF Gene Polymorphisms and Breast Cancer Risk among Chinese Women. Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1148 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Prior, J. M. Hagberg, C. M. Paton, L. W. Douglass, M. D. Brown, J. C. McLenithan, and S. M. Roth DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1848 - H1855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Faffe, L. Flynt, K. Bourgeois, R. A. Panettieri Jr., and S. A. Shore Interleukin-13 and Interleukin-4 Induce Vascular Endothelial Growth Factor Release from Airway Smooth Muscle Cells: Role of Vascular Endothelial Growth Factor Genotype Am. J. Respir. Cell Mol. Biol., February 1, 2006; 34(2): 213 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Summers, B. M. Coupes, M. F. Brennan, S. A. Ralph, C. D. Short, and P. E. C. Brenchley VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5 Nephrol. Dial. Transplant., November 1, 2005; 20(11): 2427 - 2432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Kim, Y. M. Choi, S. H. Choung, J. K. Jun, J. G. Kim, and S. Y. Moon Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis Hum. Reprod., October 1, 2005; 20(10): 2904 - 2908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Seo, S.-S. Lee, S. I. Kim, W. H. Ryu, K. H. Sa, S. U. Kim, S. W. Han, E. J. Nam, J. Y. Park, W. K. Lee, et al. Influence of VEGF gene polymorphisms on the severity of ankylosing spondylitis Rheumatology, October 1, 2005; 44(10): 1299 - 1302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bhanoori, K. Arvind Babu, N.G. Pavankumar Reddy, K. Lakshmi Rao, K. Zondervan, M. Deenadayal, S. Kennedy, and S. Shivaji The vascular endothelial growth factor (VEGF) +405G>C 5'-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study Hum. Reprod., July 1, 2005; 20(7): 1844 - 1849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Lu, X.-O. Shu, Y. Cui, N. Kataoka, W. Wen, Q. Cai, Z.-X. Ruan, Y.-T. Gao, and W. Zheng Association of Genetic Polymorphisms in the VEGF Gene with Breast Cancer Survival Cancer Res., June 15, 2005; 65(12): 5015 - 5019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W M Howell, S Ali, M J Rose-Zerilli, and S Ye VEGF polymorphisms and severity of atherosclerosis J. Med. Genet., June 1, 2005; 42(6): 485 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Jin, K. Hemminki, K. Enquist, P. Lenner, E. Grzybowska, R. Klaes, R. Henriksson, B. Chen, J. Pamula, W. Pekala, et al. Vascular Endothelial Growth Factor Polymorphisms in Relation to Breast Cancer Development and Prognosis Clin. Cancer Res., May 15, 2005; 11(10): 3647 - 3653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Lee, S. Y. Lee, H.-S. Jeon, S. H. Park, J. S. Jang, G. Y. Lee, J. W. Son, C. H. Kim, W. K. Lee, S. Kam, et al. Vascular Endothelial Growth Factor Gene Polymorphisms and Risk of Primary Lung Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 571 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Liu, F. Innocenti, M. H. Wu, A. A. Desai, M. E. Dolan, E. H. Cook Jr., and M. J. Ratain A Functional Common Polymorphism in a Sp1 Recognition Site of the Epidermal Growth Factor Receptor Gene Promoter Cancer Res., January 1, 2005; 65(1): 46 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C E Waters, A Stevens, A White, and D W Ray Analysis of co-factor function in a glucocorticoid-resistant small cell carcinoma cell line J. Endocrinol., November 1, 2004; 183(2): 375 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. I. Cooke, J. A. Drury, R. Mountford, and D. Clark Genetic Polymorphisms and Retinopathy of Prematurity Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1712 - 1715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wu, J. Richer, K. B. Horwitz, and S. M. Hyder Progestin-Dependent Induction of Vascular Endothelial Growth Factor in Human Breast Cancer Cells: Preferential Regulation by Progesterone Receptor B Cancer Res., March 15, 2004; 64(6): 2238 - 2244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ray, M. Mishra, S. Ralph, I. Read, R. Davies, and P. Brenchley Association of the VEGF Gene With Proliferative Diabetic Retinopathy But Not Proteinuria in Diabetes Diabetes, March 1, 2004; 53(3): 861 - 864. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
